Blue Slate News & Events

Blue Slate helps companies find the most secure paths to bring novel medical technologies successfully to market.

To learn more about our current efforts, please select from the articles below:

CIRECA marks a new look at Tumors, Immunity and the Micro-Environment (TIME) in the Classification and Discovery of Cancerous Cells and Immune Response using Spectral Histopathology (SHP)

Read Full Press Release >

Blue Slate’s Consulting Service Focuses on Asian Dental Market

Read Full Press Release >

Blue Slate Continues to Expand Distribution of Extremity Medical

Read Full Press Release >

Blue Slate Announces Sale of Portfolio Company, Simpact Dental

Read Full Press Release >

CellMark Theranostics Announces Corporate Renaming to Cireca Theranostics

Read Full Press Release >

Blue Slate Highlights Growth Within Orthopedic Device Development Partnership

Read Full Press Release >

Blue Slate Announces Launch of CellMark Theranostics

Read Full Press Release >